<DOC>
	<DOCNO>NCT01325233</DOCNO>
	<brief_summary>Astragalus membranaceus ( AM ) use treat stroke long time , number study show AM reduce cerebral infarction area anti-oxidation activity . PG2 , sterile powder polysaccharide isolate root astragulus ( Huang-Chi ) intravenous injection , approve botanical drug TFDA . Hemorrhagic stroke induce secondary peri-blood clot edema may increase intracranial pressure exacerbate clinical symptom . Therefore , purpose present study investigate efficacy PG2 hemorrhagic stroke .</brief_summary>
	<brief_title>The Pilot Clinical Study PG2 Injection Hemorrhagic Stroke</brief_title>
	<detailed_description>This double-blind , randomize , placebo-controlled study . An estimated 60 ( least 48 evaluable ) first hemorrhagic stroke patient randomly divide control treatment group . Each group treat follow : 1 ) control group accept placebo t.i.w treatment 14 day second day admission , addition standard ordinary treatment . ; 2 ) treatment group accept PG2 t.i.w treatment 14 day second day admission , addition standard ordinary treatment . Inflammatory index include level C-Reactive Protein ( CRP ) , Erythrocyte Sedimentation Rate ( ESR ) , S-100 protein , IL-1 , IL-6 , TNF-beta level measure clinical symptom include Glasgow outcome scale ( GOS ) , modify rankin scale ( MRS ) , Functional Independence Measure ( FIM ) Barthel Index ( BI ) evaluate study .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Intracranial Hemorrhages</mesh_term>
	<criteria>Patients confirm diagnosis first spontaneous hemorrhagic stroke Patients hemorrhagic stroke Putamen Patients admit hospital within 24 hour onset hemorrhagic stroke Patients sign informed consent form Patient hemorrhage area Putamen primary subarachnoid hemorrhage , Arteriovenous malformation ( AVM ) brain tumor hemorrhage Patient perform craniotomy Patient suffering cirrhosis , uremia dialysis , bleed tendency , severe cardiopulmonary disease mental disorder would unable comply study investigator ' decision . Patients enrol yet complete investigational drug trial within 1 month screening . Female patient pregnant breastfeeding .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>Astragulus polysaccharide</keyword>
	<keyword>Hemorrhagic stroke</keyword>
</DOC>